Sam Brusco, Associate Editor11.09.22
Exactech was granted a patent (#11,490,966) by the U.S. Patent and Trademark Office describing a method and system to predict outcomes following arthroplasty procedures.
The patent relates to Predict+, a data-driven, clinical decision support tool. The software leverages machine learning to predict patient outcomes after shoulder replacement surgery, which was released in 2020.
Predict+ is based on shoulder replacement clinical experience within a single-shoulder prosthesis outcomes database of 15,000 patients.
“Predict+ is a novel application of orthopedic clinical research and data science and represents a significant, value-creating advancement to the surgeon-patient preoperative consultation process related to shoulder arthroplasty,” Chris Roche, Exactech’s senior VP of Extremities told the press. “This granted patent strengthens Exactech’s leadership position in the orthopedic applications of artificial intelligence and features several broad claims which cover future innovations and expands Exactech’s intellectual property portfolio.”
Predict+ lets surgeons input as many as 19 patient data points and within seconds, it predicts potential outcomes like pain, function, and range of motion. It also compares predictive results for anatomic and reverse shoulder arthroplasty as multiple post-op timelines.
This can help better personalize treatment by identifying modifiable factors like the patient losing weight, quitting smoking, and completing pre-habilitation. Predict+ also aggregates outcomes and complications in the database so surgeons and patients can compare personalized predictions with the clinical experience of patient of similar age and gender.
“Developed in partnership with Advata, Predict+ showcases the predictive power of machine learning to transform healthcare,” said Vikas Kumar, Advata’s VP of Research and Machine Learning. “Predict+ delivers personalized, evidence-based predictions that objectively quantify the risk and benefit that an individual patient may experience after anatomic and reverse shoulder replacement, aligning patient and surgeon expectations for shared decision making.”
Predict+ supports shoulder arthroplasty procedures with Exactech’s Equinoxe shoulder.
The patent relates to Predict+, a data-driven, clinical decision support tool. The software leverages machine learning to predict patient outcomes after shoulder replacement surgery, which was released in 2020.
Predict+ is based on shoulder replacement clinical experience within a single-shoulder prosthesis outcomes database of 15,000 patients.
“Predict+ is a novel application of orthopedic clinical research and data science and represents a significant, value-creating advancement to the surgeon-patient preoperative consultation process related to shoulder arthroplasty,” Chris Roche, Exactech’s senior VP of Extremities told the press. “This granted patent strengthens Exactech’s leadership position in the orthopedic applications of artificial intelligence and features several broad claims which cover future innovations and expands Exactech’s intellectual property portfolio.”
Predict+ lets surgeons input as many as 19 patient data points and within seconds, it predicts potential outcomes like pain, function, and range of motion. It also compares predictive results for anatomic and reverse shoulder arthroplasty as multiple post-op timelines.
This can help better personalize treatment by identifying modifiable factors like the patient losing weight, quitting smoking, and completing pre-habilitation. Predict+ also aggregates outcomes and complications in the database so surgeons and patients can compare personalized predictions with the clinical experience of patient of similar age and gender.
“Developed in partnership with Advata, Predict+ showcases the predictive power of machine learning to transform healthcare,” said Vikas Kumar, Advata’s VP of Research and Machine Learning. “Predict+ delivers personalized, evidence-based predictions that objectively quantify the risk and benefit that an individual patient may experience after anatomic and reverse shoulder replacement, aligning patient and surgeon expectations for shared decision making.”
Predict+ supports shoulder arthroplasty procedures with Exactech’s Equinoxe shoulder.